FDA Adverse Event Injury Summary report: N

SEPRAFILM (SODIUM HYALURONATE, CARBOXYMETHYLCELLULOSE) MEMBRANE

MDR report key: 1212554 · Received October 27, 2008

Report

Report Number
1220423-2008-00037
Event Type
Injury
Date Received
October 27, 2008
Report Date
October 16, 2008
Manufacturer
GENZYME SURGERY (SEPRAFILM/PACK)
Product Code
MCN
PMA / PMN Number
P950034
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NV, US
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

PELVIC ABSCESSES [PELVIC ABCESS]. CASE DESCRIPTION SPONTANEOUS REPORT REC'D: ON 16-OCT-2008, A PHYSICIAN REGARDING A FEMALE PT, AGE AND INITIALS UNK, WHO EXPERIENCED PELVIC ABSCESSES AFTER PLACEMENT OF SEPRAFILM. THE PT WAS IDENTIFIED BY THE MFR AS PT 1 OR 5. THE PHYSICIAN REPORTED THAT HE HAD USED AN (UNSPECIFIED) HYDRATED FORM OF SEPRAFILM IN THE INITIAL (UNSPECIFIED) SURGERY WHICH WAS DONE USING THE DAVINCI ROBOTIC DEVICE (THE PHYSICIAN STATED HE HAD PERFORMED 85 TOTAL ROBOTIC CASES USING THE UNSPECIFIED HYDRATED SEPRAFILM FORMULATION). HE STATED THAT HE HAD ALSO BEGUN INJECTING MORPHINE INTO THE VAGINAL CUFF AT THE SAME TIME HE BEGAN USING THE HYDRATED SEPRAFILM. AT AN UNSPECIFIED TIME AFTER THE INITIAL SURGERY, PT PRESENTED WITH SYMPTOMS RESULTING IN AN ADD'L EXPLORATORY SURGERY AND/OR HOSPITALIZATION. SHE WAS DIAGNOSED WITH A PELVIC ABSCESS. DUE TO THE PRESENCE OF THE CO-SUSPECT DRUG, MORPHINE, HE STATED HE WAS "UNSURE OF THE CAUSAL LINK TO THE USE OF HYDRATED SEPRAFILM". HE STATED THAT SHE HAD RECOVERED AND HAD BEEN DISCHARGED TO HOME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SEPRAFILM (SODIUM HYALURONATE, CARBOXYMETHYLCELLULOSE) MEMBRANE BIORESORBABLE ADHESION BARRIER MCN GENZYME SURGERY (SEPRAFILM/PACK) UNK UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Hospitalization